Literature DB >> 8882783

Standard weight for height curves in achondroplasia.

A G Hunter1, J T Hecht, C I Scott.   

Abstract

Standard curves developed for the general population cannot be used to assess the growth of an individual who has a condition that results in disproportionate short stature. For this reason, efforts have been made to develop growth curves specific for several of the chondrodysplasias. However, data concerning weight for height have been largely lacking, although they may be of particular importance for conditions such as achondroplasia, where there is some consensus that an increased prevalence of obesity is a particular problem. In this paper we provide standard weight for height curves for males and females with achondroplasia, and discuss the use of several indices which have been applied to the assessment of body fat in the general population.

Entities:  

Mesh:

Year:  1996        PMID: 8882783     DOI: 10.1002/(SICI)1096-8628(19960329)62:3<255::AID-AJMG10>3.0.CO;2-J

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  13 in total

1.  Functional characteristics of mesenchymal stem cells derived from the adipose tissue of a patient with achondroplasia.

Authors:  Jeong-Ran Park; Hanbyeol Lee; Chung-Hyo Kim; Seok-Ho Hong; Kwon-Soo Ha; Se-Ran Yang
Journal:  In Vitro Cell Dev Biol Anim       Date:  2016-04-08       Impact factor: 2.416

2.  Disease models: Statins give bone growth a boost.

Authors:  Bjorn R Olsen
Journal:  Nature       Date:  2014-09-17       Impact factor: 49.962

Review 3.  Low Energy Availability, Menstrual Dysfunction, and Low Bone Mineral Density in Individuals with a Disability: Implications for the Para Athlete Population.

Authors:  Cheri A Blauwet; Emily M Brook; Adam S Tenforde; Elizabeth Broad; Caroline H Hu; Eliza Abdu-Glass; Elizabeth G Matzkin
Journal:  Sports Med       Date:  2017-09       Impact factor: 11.136

4.  Growth references for height, weight, and head circumference for Argentine children with achondroplasia.

Authors:  Mariana del Pino; Virginia Fano; Horacio Lejarraga
Journal:  Eur J Pediatr       Date:  2010-10-12       Impact factor: 3.183

Review 5.  Disease-specific complications and multidisciplinary interventions in achondroplasia.

Authors:  Hiroshi Kitoh; Masaki Matsushita; Kenichi Mishima; Yasunari Kamiya; Kenta Sawamura
Journal:  J Bone Miner Metab       Date:  2022-01-14       Impact factor: 2.626

Review 6.  Achondroplasia: a comprehensive clinical review.

Authors:  Richard M Pauli
Journal:  Orphanet J Rare Dis       Date:  2019-01-03       Impact factor: 4.123

7.  Early postnatal soluble FGFR3 therapy prevents the atypical development of obesity in achondroplasia.

Authors:  Celine Saint-Laurent; Stephanie Garcia; Vincent Sarrazy; Karine Dumas; Florence Authier; Sophie Sore; Albert Tran; Philippe Gual; Isabelle Gennero; Jean-Pierre Salles; Elvire Gouze
Journal:  PLoS One       Date:  2018-04-13       Impact factor: 3.240

8.  Clinical Practice Guidelines for Achondroplasia.

Authors:  Takuo Kubota; Masanori Adachi; Taichi Kitaoka; Kosei Hasegawa; Yasuhisa Ohata; Makoto Fujiwara; Toshimi Michigami; Hiroshi Mochizuki; Keiichi Ozono
Journal:  Clin Pediatr Endocrinol       Date:  2020-01-09

9.  Development of the Screening Tool for Everyday Mobility and Symptoms (STEMS) for skeletal dysplasia.

Authors:  Penelope J Ireland; Ravi Savarirayan; Tash Pocovi; Tracy Tate; Marie Coussens; Louise Tofts; Craig Munns; Verity Pacey
Journal:  Orphanet J Rare Dis       Date:  2021-01-21       Impact factor: 4.123

Review 10.  Optimal management of complications associated with achondroplasia.

Authors:  Penny J Ireland; Verity Pacey; Andreas Zankl; Priya Edwards; Leanne M Johnston; Ravi Savarirayan
Journal:  Appl Clin Genet       Date:  2014-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.